Specialized Working Group on Acute Myeloid Leukemia

Overview

The primary aim of the Acute Myeloid Leukemia (AML) SWG is to provide a forum for translational research by bridging the gaps between: 

  • Basic scientists  
  • Clinicians treating AML patients 

We represent a group of national and internationally renowned clinical and research experts working in the field of AML and our activities include: 

  • The design of clinical studies 
  • Studies on supportive care and quality of life aspects 
  • The development of guidelines/recommendations 
  • A broad spectrum of research initiatives, with a focus on the characterization of the biological aspects of AML (genomic/multiomic and functional) 

We also aim to contribute to collecting and linking harmonized real-world datasets. By doing so, we can help to promote precision medicine and the generation of reliable evidence for regulatory and research purposes. 

The AML SWG is continuously expanding the already well-established international AML network and initiating novel cooperation and research activities. 

We support the integration and development of young AML researchers and clinicians by: 

  • Providing them with networking opportunities 
  • Involving them in clinical and research activities at an early and formative stage of their careers, thus developing the future European thought leaders in AML 

Finally, operating under the umbrella of EHA, the AML SWG is closely involved in numerous EHA activities including: 

  • Education 
  • Research 
  • European affairs 
  • Health technology assessment 
  • Big data 
  • The HARMONY Alliance Foundation 

Join us

If you work in our field and share our mission to advance our understanding and treatment of AML, you’d be welcome to join our SWG. However, before you apply, we recommend you read our application guidance. 

Ready? Apply to join us on the EHA Portal.  

If you have any questions, please email our SWGs team. 

Highlights Chairs and members Educational activities Publications
Share